In focus
Latest feed
High Court Steps In: Maharashtra FDA Retracts Cipla Drug Licence Cancellation for Pune Facility
Alnylam's Heart-Stopping Ambition: Reshaping Cardiovascular Care at ESC
Johnson & Johnson: A Premium Price for a Premium Company – But Is It Too Rich Right Now?
FDA Greenlights Zenbexus: A New Era for Multiple Myeloma Treatment
